Cancer Developmental Projects Awardees | NYU Langone Health

Skip to Main Content
Cancer Developmental Projects Program Cancer Developmental Projects Awardees

Cancer Developmental Projects Awardees

Our cancer development project awardees receive funds to conduct research projects designed to advance the treatment of cancer.

2020 Developmental Projects Program Awardees

Benjamin G. Neel, MD, PhD, and Shohei Koide, PhD
Generating and assessing immune responses to covalent anti-cancer drug target complexes

John T. Poirier, PhD, and Thales Y. Papagiannakopolous, PhD
In vivo modeling of complex lung cancer genotypes by in situ high-dose-rate (HDR) brachytherapy

Jane Skok, PhD, and Aristotelis Tsirigos, PhD
Dynamic regulation of cancer therapy resistance genes via three-dimensional contacts with non-coding regulatory elements

Jun Wang, PhD, and Alec Kimmelman, MD, PhD
Siglec-15 as a novel immune evasion mechanism for KRAS mutant pancreatic cancer

2019 Developmental Projects Program Awardees

Lorna E. Thorpe, MPH, PhD
Developing and validating model cancer surveillance measures for NYC and its neighborhoods using electronic health record data

Stacy Loeb, MD
Using a user-centered design framework to develop a tailored sleep health improvement program (SHIP) for prostate cancer patients and caregivers

Aristotelis Tsirigos, PhD
Integrated characterization of histological and molecular tumor heterogeneity using deep learning

Itai Yanai, PhD, and Jeffrey S. Weber, MD, PhD
Building a human melanoma atlas for personalized immunotherapy treatment

Theodore H. Welling, MD, and Itai Yanai, PhD
Therapeutic targeting of tumor-associated macrophages in hepatocellular carcinoma

2018 Developmental Projects Program Awardees

Ken H. Cadwell, PhD and Jeffrey S. Weber, MD, PhD
Role of enteric virome on immune-checkpoint blockade efficacy and toxicity

Stella S. Yi, MPH, PhD, Ophira M. Ginsburg, MD, and Mary E. Northridge, MPH, PhD
Prevention of HPV-related cancer disparities through chairside screening and vaccination referral

2017 Developmental Projects Program Awardees

Michael E. Pacold, MD, PhD, and Diane M. Simeone, MD
Targeting lipoic acid–dependent metabolism in pancreatic cancer

Evgeny A. Nudler, PhD
Using maximum-depth sequencing for liquid biopsy detection of lung cancer

2016 Developmental Projects Program Awardees

Jiyoung Ahn, PhD, and Jeffrey S. Weber, MD, PhD
Human gut microbiome and immunotherapy outcomes in melanoma patients

Dafna Bar-Sagi, PhD, and Deirdre J. Cohen, MD
A phase Ib study combining irinotecan with AZD-1775, a selective WEE1 inhibitor, in RAS (KRAS or NRAS)- or BRAF-mutated metastatic colorectal cancer patients who have progressed on first-line therapy

2015 Developmental Projects Program Awardees

Arjun V. Balar, MD
The immune microenvironment of localized high-grade invasive urothelial bladder cancer

Lawrence Gardner, MD
Exploiting the role of NMD inhibition in cancer for therapeutic gain

Tony T. Huang, PhD
Deubiquitinases as potential therapeutic targets for the treatment of multiple myeloma

Jennifer Wu, MD
Modulation of tumor-promoting influences of γδT cells in a phase Ib clinical trial utilizing novel immunotherapy regimens for advanced pancreatic carcinoma